Marine Peptides Forecast by Fish and Shellfish from 2023 to 2033

<p>The net worth of the market for peptides derived from the sea is estimated to be around US$ 273.8 million in 2023. The<strong> global marine peptide</strong> industry is predicted to grow at a moderate rate of 5.8% from 2023 to 2033. The overall marine peptide supplements market share is estimated to reach a value of nearly US$ 481.7 million by the end of this projected period.</p><table><tbody><tr><th scope='row'>Report Attribute</th><td>Details</td></tr><tr><th scope='row'>Marine Peptides Market Size (2023)</th><td>US$ 273.8 million</td></tr><tr><th scope='row'>Market Anticipated Forecast Value (2033)</th><td>US$ 481.7 million</td></tr><tr><th scope='row'>Market Projected Growth Rate (2023 to 2033)</th><td>5.8%</td></tr></tbody></table><p>Global Marine Peptides Market Analysis During Historical Period from 2018 to 2022 Compared to Forecast Outlook for 2023 to 2033</p><table><tbody><tr><th scope='row'>Attributes</th><td>Details</td></tr><tr><th scope='row'>Marine Peptides Market Growth (2018 to 2022)</th><td>2.4%</td></tr><tr><th scope='row'>Market Size (2022)</th><td>US$ 245.6 million</td></tr><tr><th scope='row'>Market Size (2018)</th><td>US$ 223 million</td></tr></tbody></table><p>Country-wise Insights</p><table><tbody><tr><th scope='row'>Countries</th><td>CAGR (2023 to 2033)</td></tr><tr><th scope='row'>United Kingdom</th><td>9.8%</td></tr><tr><th scope='row'>India</th><td>11.7%</td></tr><tr><th scope='row'>China</th><td>13.5%</td></tr></tbody></table><p>Marine Peptides Market Report Scope</p><table><tbody><tr><th scope='row'>Attribute</th><td>Details</td></tr><tr><th scope='row'>Forecast Period</th><td>2023 to 2033</td></tr><tr><th scope='row'>Historical Data Available for</th><td>2018 to 2022</td></tr><tr><th scope='row'>Market Analysis</th><td>US$ million or billion for Value and Units for Volume</td></tr><tr><th scope='row'>Key Regions Covered</th><td>North America, Latin America, Europe, Middle East &amp; Africa (MEA), East Asia, South Asia and Oceania</td></tr><tr><th scope='row'>Key Countries Covered</th><td>United States, Canada, Brazil, Mexico, Germany, Spain, Italy, France, United Kingdom, Russia, China, India, Australia &amp; New Zealand, GCC Countries, and South Africa</td></tr><tr><th scope='row'>Key Segments Covered</th><td>By Product Type, By End Use, and By Region</td></tr><tr><th scope='row'>Key Companies Profiled</th><td><ul><li>Amicogen Inc.</li><li>Cargill Inc.</li><li>China Peptides</li><li>Darling Ingredients</li><li>Gelita AG</li><li>Guangzhou Honsea Sunshine Bio Science &amp; Technology</li><li>Lapi Gelatine</li><li>Nippi Collagen</li><li>Nitta Gelatin</li><li>PB Gelatins or PB Leiner</li><li>Rousselot (Peptan)</li><li>Trobas Gelatine B.V.</li><li>Vital Proteins LLC.</li><li>Weishardt Gelatines</li><li>Wellnex</li></ul></td></tr><tr><th scope='row'>Report Coverage</th><td>Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives</td></tr><tr><th scope='row'>Customization &amp; Pricing</th><td>Available upon Request</td></tr></tbody></table>

<p>据预测，2023年，源自海洋的肽类市场估值约为2.738亿美元。全球海洋肽产业预计将从2023年至2033年以5.8%的适中增速发展。在此预测期内，海洋肽补充剂市场的整体份额预计将达到近4.817亿美元的规模。</p><table><tbody><tr><th scope='row'>报告属性</th><td>详细信息</td></tr><tr><th scope='row'>海洋肽市场规模（2023年）</th><td>2.738亿美元</td></tr><tr><th scope='row'>市场预期预测价值（2033年）</th><td>4.817亿美元</td></tr><tr><th scope='row'>市场预期增长率（2023年至2033年）</th><td>5.8%</td></tr></tbody></table><p>与2018年至2022年历史时期的全球海洋肽市场分析相比，2023年至2033年的预测展望</p><table><tbody><tr><th scope='row'>属性</th><td>详细信息</td></tr><tr><th scope='row'>海洋肽市场增长率（2018年至2022年）</th><td>2.4%</td></tr><tr><th scope='row'>市场规模（2022年）</th><td>2.456亿美元</td></tr><tr><th scope='row'>市场规模（2018年）</th><td>2.23亿美元</td></tr></tbody></table><p>各国市场洞察</p><table><tbody><tr><th scope='row'>国家</th><td>复合年增长率（2023年至2033年）</td></tr><tr><th scope='row'>英国</th><td>9.8%</td></tr><tr><th scope='row'>印度</th><td>11.7%</td></tr><tr><th scope='row'>中国</th><td>13.5%</td></tr></tbody></table><p>海洋肽市场报告范围</p><table><tbody><tr><th scope='row'>属性</th><td>详细信息</td></tr><tr><th scope='row'>预测期</th><td>2023年至2033年</td></tr><tr><th scope='row'>可获取历史数据</th><td>2018年至2022年</td></tr><tr><th scope='row'>市场分析</th><td>价值以百万或十亿美元计，体积以单位计</td></tr><tr><th scope='row'>涵盖的主要地区</th><td>北美、拉丁美洲、欧洲、中东及非洲（MEA）、东亚、南亚和大洋洲</td></tr><tr><th scope='row'>涵盖的主要国家</th><td>美国、加拿大、巴西、墨西哥、德国、西班牙、意大利、法国、英国、俄罗斯、中国、印度、澳大利亚及新西兰、GCC国家、南非</td></tr><tr><th scope='row'>涵盖的主要细分市场</th><td>按产品类型、按用途和按地区</td></tr><tr><th scope='row'>主要公司简介</th><td><ul><li>Amicogen Inc.</li><li>Cargill Inc.</li><li>China Peptides</li><li>Darling Ingredients</li><li>Gelita AG</li><li>广州宏海阳光生物科技有限公司</li><li>Lapi Gelatine</li><li>Nippi Collagen</li><li>Nitta Gelatin</li><li>PB Gelatins or PB Leiner</li><li>Rousselot (Peptan)</li><li>Trobas Gelatine B.V.</li><li>Vital Proteins LLC.</li><li>Weishardt Gelatines</li><li>Wellnex</li></ul></td></tr><tr><th scope='row'>报告覆盖范围</th><td>市场预测、公司份额分析、竞争情报、DROT分析、市场动态和挑战、以及战略增长举措</td></tr><tr><th scope='row'>定制与定价</th><td>根据要求提供</td></tr></tbody></table>